Remdesivir Distribution Causes Confusion, Leaves Some Hospitals Empty-Handed

By Sydney Lupkin

Published May 14, 2020 at 9:12 AM MDT

Facebook
Twitter
LinkedIn
Email

Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices.

NPR Coronavirus Updates

Facebook
Twitter
LinkedIn
Email

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR.

See stories by Sydney Lupkin